|
TODAY'S HEADLINES
The Food and Drug Administration has granted accelerated approval to Keytruda (pembrolizumab, Merck) for treatment of advanced or unresectable melanoma in patients who have stopped responding to other drugs. » Find out more
|
ADVERTISEMENT
Cosmetic Surgery Forum: Dec. 3 – 6, 2014 in Las Vegas, Nev
Cosmetic Surgery Forum features live demos and interactive presentations covering the latest in dermatology and cosmetic surgery. Join us Dec. 3-6 at the Palazzo Hotel in Las Vegas and earn 22 CME credits!
 Read More
|
|
Members of the military have a high risk of contracting skin cancer, due in part to the climates where they are deployed, recent research suggests. And only a small portion of service members is aware of the risks of sun exposure. » See the findings
|
ADVERTISEMENT
Learn about better treatments for nonmelanoma skin cancer
This free, 1-hour Dermatology Times webinar will teach you more about the role of radiation oncology, relevant case reviews, clinical evidence, appropriate patient selection, and more. Click here to register.
 Click here to register.
|
|
A small adhesive patch topped with microneedles may allow clinicians to deliver collagen more deeply and without pain to the patient. » Find out how it works
|
ADVERTISEMENT
Best practices in the evaluation and management of actinic keratoses
Articles, video, tools and CME on current strategies for managing actinic keratoses lesions using a variety of therapeutic approaches based on efficacy, safety and tolerability.
 Read More
|
|
Treatment of chronic pruritus requires recognizing that its origins might not be as clear-cut as formerly thought, an expert says.
» Read about therapies
|
|
|
Like
Tweet
